Tuesday, 17 November 2026 Every SEC filing alert, by company
ALFA USA Filings Every alert, straight from SEC EDGAR
News

Repligen Corp

NASDAQ: RGEN · Life Sciences · 7 alerts · CIK 730272

Share price
$162.78Close, Nov 16
Market cap
$10.4B
Shares outstanding
63.92MLatest SEC cover page
Sector
Life Sciences
Industry
Biological Products, (No Diagnostic Substances)SIC 2836

Today's reference numbers: shares from the company's latest SEC cover page, price from the latest market close. Not a valuation or a recommendation. All Repligen Corp filings on SEC EDGAR ↗

4:02 PM ET 8-K
Loan & Debt

Repligen $1B Debt Financing with U.S. Bank Trust Company, National Association

Repligen Corporation issued $1.0 billion in 0.25% Convertible Senior Notes due 2031. The transaction included $541.4 million issued in exchange for existing 2028 notes and $458.6 million issued for cash to manage the company's debt maturity profile and capital structure.

Value
$1B
Counterparty
U.S. Bank Trust Company, National Association
Term
through Nov 2031
6:13 AM ET 8-K
Loan & Debt

Repligen $1B Debt Financing

Repligen Corporation entered into agreements to issue $1.0 billion in 0.25% Convertible Senior Notes due 2031. The transaction includes $541.4 million in notes issued to exchange existing 1.00% notes due 2028 and $458.6 million in notes issued for cash to new investors.

Value
$1B
Term
through Nov 2031

Get Alerts

Get ALFA Finder alerts first

Real-time SEC filing alerts for US stocks are launching soon. Leave your details and we'll tell you the moment they go live.